A material or mixture of materials which is not itself storage stable is rendered storage stable by incorporation into a water-soluble or swellable glassy or rubbery composition which can then be stored at ambient temperature. Recovery is by adding aqueous solution to the composition.

Patent
   RE39497
Priority
Feb 16 1989
Filed
Aug 28 2001
Issued
Feb 27 2007
Expiry
Feb 12 2010
Assg.orig
Entity
unknown
19
50
EXPIRED
0. 18. A composition which is storage-stable at 20° C., comprising:
(1) a carrier substance which is water-soluble or water-swellable and
(2) at least one material to be stored which is dissolved in said carrier substance;
wherein said composition has the property that it exists in a glassy state when at 20° C.;
wherein said at least one material comprises a purified biologically active material that is unstable in aqueous solution at 20° C.;
wherein said biologically active material is selected from the group consisting of peptides, proteins, nucleosides, nucleotides, dimers or oligomers of nucleosides or nucleotides, enzymes, enzyme cofactors and derivatives of any of the foregoing, said
with proviso that when said at least one material comprises an enzyme, said enzyme comprises an enzyme selected from restriction enzymes, dehydrogenase enzymes, oxidase enzymes, and reductase enzymes.
0. 17. A composition which is storage-stable at 20° C., comprising:
(1) a carrier substance which is water-soluble or water-swellable and is in a glassy state;
(2) at least one material to be stored which is dissolved in said carrier substance;
wherein said composition exists in a glassy state at 20° C.;
wherein said at least one material comprises a purified biologically active material that is unstable in aqueous solution at 20° C.;
wherein said purified biologically active material is selected from the group consisting of peptides, proteins, nucleosides, nucleotides, dimers or oligomers of nucleosides or nucleotides, enzymes, enzyme cofactors and derivatives of any of the foregoing, said derivatives having one or more additional moieties bound thereto;
wherein said composition contains no more than 4 percent by weight of water; and
wherein said biological active material is not rennin.
0. 19. A composition which is storage-stable at 20° C., comprising:
(1) a carrier substance which is water-soluble or water-swellable and
(2) at least one material to be stored which is dissolved in said carrier substance;
wherein said composition has the property that it exists in a glassy state when at 20° C;
wherein said at least one material comprises a purified biologically active material that is unstable in aqueous solution at 20° C;
wherein said biologically active material is selected from the group consisting of peptides, proteins, nucleosides, nucleotides, dimers or oligomers of nucleosides or nucleotides, enzymes, enzyme cofactors and derivatives of any of the foregoing, said derivatives having one or more additional moieties bound thereto; and
wherein said biologically active material is not freeze stable; and
with proviso that when said at least one material comprises an enzyme, said enzyme comprises an enzyme selected from dehydrogenase enzymes, restriction enzymes, oxidase enzymes, and reductase enzymes.
0. 1. A composition which is storage stable at 20° C. comprising:
i) a carrier substance which is water-soluble or water-swellable and is in a glassy amorpous state;
ii) at least one material to be stored, which is unstable in aqueous solution at room temperature of 20° C. dissolved in said amorphous carrier substance, said composition existing in a glassy state at 20° C.
0. 2. A composition according to claim 1 wherein the material to be stored is selected from proteins, peptides, nucleosides, nucleotides, dimers or oligomers of nucleosides or nucleotides, enzyme cofactors, and derivatives of any of the foregoing having one or more additional moieties bound thereto.
0. 3. A composition according to claim 1 having a water content not exceeding 4% by weight.
0. 4. A composition according to claim 1 wherein the composition displays a glass transition temperature of at least 30° C.
0. 5. A composition according to claim 1 wherein carrier substance is selected from carbohydrates and derivatives thereof which are polyhydroxy compounds.
0. 6. A composition according to claim 5 wherein the carrier substance is a sugar polymer containing sugar residues linked through ether bridges to bifunctional groups other than carbohydrate.
0. 7. A composition according to claim 1 wherein the carrier substance is a synthetic polymer.
0. 8. A composition according to claim 1 wherein said material to be stored comprises a material which is unstable when alone in aqueous solution at room temperature.
0. 9. A composition according to claim 1 wherein said material to be stored comprises a plurality of materials.
0. 10. A composition according to claim 9 wherein said material to be stored comprises a plurality of materials which react together in aqueous solution.
0. 11. A composition according to claim 1 which can be stored without refrigeration for at least 1 week.
0. 12. A method of rendering a material storage stable a 20° C., which material is unstable in aqueous solution at room temperature of 20° C., comprising dissolving the material in a carrier substance which is water-soluble or water-swellable, or to a solution thereof, so that the material is dissolved in said carrier substance, and forming the resulting mixture into a glassy amorphous state, said mixture existing in said glassy state at 20° C.
0. 13. A method according to claim 12 wherein forming the said mixture into an amorphous state is effected by evaporation under subatmospheric pressure.
0. 14. A method according to claim 13 wherein evaporation is commenced at a temperature of 20 to 40° C. and subsequently continued at a temperature of 40 to 70° C.
0. 15. A method according to claim 13 wherein the subatmospheric pressure is not greater than 90% of atmospheric.
0. 16. In a method of storing a material, which material is unstable in aqueous solution at 20° C., the improvement comprising dissolving the material in a carrier substance which is water-soluble or water-swellable, or in a solution thereof, so that the material is dissolved in said carrier substance, forming the resulting mixture into a glassy amorphous state and storing the mixture in said glassy amorphous state without refrigeration for at least one week.


where I is the initial LDH activity (units/ml) in the solution used to prepare the glass.

The preparation was assayed periodically for LDH activity, as described in Example 1. No loss of activity could be detected after 1 month storage at 25° C.

The glass temperature of the preparation was determined by differential scanning calorimetry as 32° C.

To 1 g Ficoll 400 were added 100 μl of a solution of EcoR I restriction endonuclease in 50% aqueous glycerol and a glass was prepared as described in Example 1. The final preparation was stored for 10 days in the laboratory with temperatures fluctuating between 20 and 30° C.

A quantity of the preparation equivalent to 2 units of enzyme, based on the assumption that the enzyme was still fully active, was dissolved in the following buffer: 100 mM Tris-HCl pH 7.5. 10 mM MgCl2. 50 mM NaCl. 0.1 mg/ml bovine serum albumin. An assay for enzyme activity was carried out by the following procedure (which is taken from LKB Laboratory Manual: LKB 2013 Miniphor Submarine Electrophoresis Unit 1985, Chapter 6). The solution was incubated with 1 μg lamda-DNA for 1 hour at 37° C. Electrophoresis of the incubation mixture was then carried out on Q.5% agarose gel in Tris/borate buffer in standard manner. The DNA breakdown bands observed on the gel corresponded exactly with those of a control run with a fresh enzyme solution.

A solution containing 100 mg/ml NADH and 33 mg/ml pyruvate was prepared. 0.4 ml of this solution were incorporated into 4 g of a sucrose glass and the mixture processed, as described in Example 2. The mixed glass was stored in 20 mg quantities in spectrophotometer cuvettes which were closed with sealing film and kept in a laboratory where the temperature fluctuated between 20 and 35° C. The glass was stored for 14 days.

For purposes of assay, the contents of a cuvette were dissolved in 2.7ml of 0.01M phosphate buffer (pH 7.0) and 0.1 ml of a LDH solution containing 1 unit/ml was added. The absorbance at 340 nm was recorded at 30 second intervals for a total period of 3 minutes and the temperature of the solution was measured. The apparent LDH enzyme activity was determined from the period during which the absorbance change was linear with time. The activity was calculated as in Example 1. A control assay was carried out with fresh solutions of NADH and pyruvate. The apparent activity obtained using the dissolved glass closely matched the control value.

The active material was glutamate dehydrogenase. 532 mg of Ficoll 400 DL as used to Example 1 was added to 20 ml of a glutamate dehydrogenase solution, containing 13.3 mg/ml protein. The protein:Ficoll ratio was therefore 1.2. The sample was then divided into eighty 0.25 ml portions and dried at 37° C. under reduced pressure (about 80% of atmospheric) for 24 hours. The sample was then divided into two batches of 40 vials. One batch was heated under reduced pressure for a further two hours at 60° C. The batches were then further subdivided and stored under a range of conditions (see below). Vials were periodically rehydrated by adding 2.23 ml of 50 mM Tris/HCl buffer at pH 7.5, containing 0.3 mM EDTA to give a solution which, assuming no loss of activity, would have contained 100 units of enzyme per ml. This was serially diluted to 1 unit/ml in the same buffer. The actual activity of the recovered enzyme was determined. The assay procedure for recovered enzyme made use of the following solutions:

Solutions

To carry out the assay 2.6 ml of solution 4.0.2 ml of solution 3 and 0.1 ml of solution 2 were mixed in a 3 ml cuvette. 0.1 ml of the recovered enzymes solution was added. The absorbance at 340 nm was observed over 5 minutes and the activity of the enzyme calculated from the change (ΔA) in absorbance during the 5 minute period. Activity was calculated using the following formula: Activity  (units/ml) = Δ A × 3 5 × 0.622

The results obtained are set out in the following Table in which “initial activity” denotes the activity of enzyme which was recovered after only a minimal period of storage. The activities are quoted as percentages of the theoretical value of activity assuming this had been retained fully. A quantity of a commercially freeze-dried glutamate dehydrogenase (whose activity before freeze drying was stated by the supplier) was divided into several portions and stored at 25° C. for varying periods and assayed in the same way. Its activity is also quoted as percentages of the theoretical activity. The results for this material ar included in the Table.

Process Storage
Temp- Temp- Initial Duration of Storage (weeks)
erature erature Activity 1 2 3 4 6 12
37° C. ambient 97% 95% 99% 98% 86%
37° C. 35° C. 97% 78% 82% 87% 84%
37° C. 25° C. 130% 122% 121% 83% 69% 74%
60° C. ambient 103% 109% 96% 85% 98% 97%
60° C. 35° C. 103% 102% 105% 96% 116%
60° C. 25° C. 121% 114% 125% 84% 81% 89%
Freeze- 25° C. 56% 40% 35% 33% 36%
dried

As can be seen from these results, experimental error gives rise to some variation in FIGURES, but these do nevertheless show very substantial retention of activity over prolonged storage and much better retention of activity than with freeze-dried material.

2.50 ml of ascorbate oxidase (21.25 mg protein) solution was prepared. To this was added 2.50 ml of Tris buffer pH 7.6 containing 21.25 mg Ficoll 400, giving a protein:Ficoll weight ratio of 1:1. This was then divided into ten 0.5 ml portions and dried at 37° C. under reduced pressure of about 80% of atmospheric for 24 hours. The samples were next heated, still under reduced pressure, for a further two hours at 60° C. Storage was on a laboratory shelf (temperature fluctuations between 17 and 28° C.). After varying periods of storage, samples were rehydrated by addition of 2.5 ml of 0.4 mM Na2HPO4 containing 0.5% Bovine serum albumin. It was then serially diluted to more of the same solution so that its activity would be 0.2 units/ml, if activity had been fully retained, and assayed. The activity relative to the starting value was determined.

Assay was carried out using a standard assay procedure published by Boeringer Mannheim. The assay monitors the decrease in absorbance at 245 nm as the enzyme catalyses the oxidation of a known solution of ascorbic acid. Enzyme which had been stored for 2 months at 35° C. was found, within the limits of experimental error, to have the same activity as enzyme which was stored for only a very short time.

Lactate dehydrogenase was incorporated into Ficoll 400 using the procedure of Example 5. The Ficoll:enzyme ratio was 0.23:0.26. Samples were stored for various periods and then recovered by adding 0.01M phosphate buffer in a quantity which would give a theoretical activity of 1 unit/ml, assuming full retention of activity. The recovered solutions were assayed using the procedure set out in Example 1. The measured activity of recovered material, as a percentage of the theoretical activity was:

Before Storage period (days)
Drying 1 14 21 28 35 180
100% 91% 81% 91% 112% 97% 98%

Cytochrome C reductase was incorporated into Ficoll 400 by the procedure of Example 5. The ratio of enzyme:Ficoll was 1:1. Samples were subjected to an accelerated test, viz. stored for 14 days at 35° C., and then recovered by adding 4 ml of 0.2M KHCO3 to give a solution with a theoretical activity of 0.87 unit/ml assuming full retention of activity. The recovered material was assayed using a procedure given in “Methods in Enzymology” by Mahler, Volume II 1955 p. 688. It was found that the recovered material had an activity of 88% of the theoretical value.

Glycerol-3-phosphate dehydrogenase was incorporated into Ficoll 400 by the procedure of Examples. The ratio of enzyme:Ficoll was 1:2. Samples were subjected to an accelerated storage test by storage at 35° C. After 7 days storage the material was recovered by adding 0.05M Tris/HCl buffer at pH 7.6. This also contained 2 mg/ml albumin and 0.74 mg/ml EDTA. The recovered material was assayed using a procedure published by Biozyme Laboratories in which the enzyme catalyses the reaction: ##STR00001##
and the oxidation of NADH is followed spectrophotometrically at 340 nm.

It was found that after 7 days storage at 35° C. the activity was 96% of the activity of a control sample which was rehydrated immediately after being incorporated into Ficoll.

Alpha-glucosidase was incorporated into Ficoll 400 using the procedure of Example 5. The Ficoll:enzyme ratio was 1:1. As an accelerated test, samples were stored for various periods at 35° C. and then recovered by adding 4 mls of 0.067M phosphate buffer at pH 7.0 to give a solution whose theoretical activity, assuming full retention of activity, was 2 units/ml. The recovered solutions were assayed by a procedure described by H. Halvorson, Methods in Enzymology 8 559 (1966). The actual activity of recovered material relative to the theoretical value was:

Before Storage period (days at 35° C.)
Drying 1 4 11 90
100% 100% 103% 95% 70%

Pyruvate: 5 g of Ficoll 400 was added to 20 ml of 10 mM sodium pyruvate solution. The solution was then divided into 40 portions, each containing 0.25 ml portions and processed in the manner described for Example 5 to give glasses.

NADH: 5 g of Ficoll 400 was added to 20 ml of a 2 mg/ml NADH solution. This was divided into 40 portions, each containing 0.25 ml, and processed as in Example 5 to give glasses.

At intervals following storage one sample of each reagent was rehydrated and the solutions mixed. They were assayed by the standard method described in Example 4. After 3 months storage at ambient temperature their ability to react in the LDH assay was 100% of the control value obtained at the initiation of storage.

NADH and pyruvate were processed as in Example 11. Portions of each resulting glass powder were mixed together. One such mixture was at once rehydrated and assayed by the procedure of Example 4. The reaction mixture consisted of 2.8 mls 0.01M phosphate buffer, 0.1 ml of rehydrated NADH/pyruvate mixture, and 0.1 mls of 1 unit/ml enzyme solution. The change in absorbance at 340 nm over three minutes was defined as 100%.

A further mixture was stored for one week and then rehydrated and assayed in the same way. Within the limits of experimental error, its activity was the same. Thus there had been no reaction of the NADH and pyruvate during storage.

A range of carrier materials were used in a standard procedure in which the stored active material is lactate dehydrogenase. In each case, a solution consisting of 0.05 g of carrier dissolved in 100 ml 0.01M phosphate buffer was prepared. 1 ml of 10 mg/ml lactate dehydrogenase solution was then added to 20 ml of the prepared solution. The solution thus created was divided into 0.5 ml aliquots in glass vials. These were dried under reduced pressure of about 80% atmospheric in a vacuum oven at 36° C. for 24 hours. After drying the vials were sealed and stored at ambient temperature. The product had a carrier:protein ratio by weight of 1:0.22.

Some samples were rehydrated immediately by addition of phosphate buffer. Others were stored for various lengths of time and then rehydrated. The activity of enzyme was determined as in Example 1. Activity of enzyme is expressed, in each case, as activity relative to that of enzyme rehydrated in the first week after drying. Results are set out in the following Table, in which “PVP” denotes polyvinylpyrollidone, “GPS” denotes 6-O-α-D-glucopyranosyl-D-sorbitol. “Palatinit” is a product of Südzucker Aktiengesellschaft, Mannheim-Ochsenfurt. Germany, and consisting of an equimolecular mixture of α-D-glucopyranosyl-1,6-mannitol and α-D-glucopyranosyl-1,6-sorbitol.

Storage period at 25° C. (weeks)
Carrier 1 2 3 4 5 6 8 10 12 16
Malto- 100 114 91 96 68 71 101 94
trose
Poly- 100 132 123 103 116 146 103
dextrose
Inulin 100 99 91 95 114 98 91
Stachy- 100 122 137 140 109 106 127
ose
Dextran 100 81 71 89 102 91 95 84
Sorbose 100 93 75 76 55 66 65 58 62
Poly- 100 100 80 71 53 62 55 63
acryl-
amide
PVP 100 75 76 70 62
GPS 100 124
Pala- 100 99
tinit

Franks, Felix, Hatley, Ross H. M.

Patent Priority Assignee Title
10064404, Jun 10 2014 BIOMATRICA, INC Stabilization of thrombocytes at ambient temperatures
10568317, Dec 08 2015 Biomatrica, Inc. Reduction of erythrocyte sedimentation rate
10772319, Jun 10 2014 Biomatrica, Inc. Stabilization of thrombocytes at ambient temperatures
11116205, Dec 08 2015 Biomatrica, Inc. Reduction of erythrocyte sedimentation rate
11672247, Jun 10 2014 Biomatrica, Inc. Stabilization of thrombocytes at ambient temperatures
12089588, Dec 08 2015 Biomatrica, Inc. Reduction of erythrocyte sedimentation rate
12121022, Jun 10 2014 Biomatrica, Inc. Stabilization of thrombocytes at ambient temperatures
7947649, Apr 14 2008 Advanced Technologies and Regenerative Medicine, LLC Liquid buffered GDF-5 formulations
7956028, Dec 14 2006 DePuy Orthopaedics, Inc; Depuy Spine, Inc; HAND INNOVATIONS LLC Protein stabilization formulations
7964561, Jun 29 2007 Advanced Technologies and Regenerative Medicine, LLC Protein formulations for use at elevated temperatures
8058237, Aug 07 2007 Advanced Technologies & Regenerative Medicine, LLC Stable composition of GDF-5 and method of storage
8435943, Dec 14 2006 Depuy Synthes Products, LLC Protein stabilization formulations
8895506, Dec 14 2006 Depuy Synthes Products, LLC Protein stabilization formulations
8900856, Apr 08 2004 BIOMATRICA, INC Integration of sample storage and sample management for life science
9078426, Apr 08 2004 Biomatrica, Inc. Integration of sample storage and sample management for life science
9376709, Jul 26 2010 BIOMATRICA, INC Compositions for stabilizing DNA and RNA in blood and other biological samples during shipping and storage at ambient temperatures
9725703, Dec 20 2012 MXCGLOBAL INC Formulations and methods for stabilizing PCR reagents
9845489, Jul 26 2010 BIOMATRICA, INC Compositions for stabilizing DNA, RNA and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
9999217, Jul 26 2010 BIOMATRICA, INC Compositions for stabilizing DNA, RNA, and proteins in blood and other biological samples during shipping and storage at ambient temperatures
Patent Priority Assignee Title
125714,
1855591,
2457036,
2648609,
3300474,
3413198,
3456050,
3480468,
3554767,
3694547,
4157386, May 18 1978 Soft, chewable lozenge forming a sticky coating on teeth when combined with saliva in the mouth which is removable only by brushing
4372942, Aug 13 1981 BEECHAM INC A CORP OF Candy base and liquid center hard candy made therefrom
4423086, Oct 17 1979 Roquette Freres Process for hard coating with sorbitol and products obtained thereby
4551329, Jan 20 1984 Joan, Harris Oral medicament lollipop
4587267, Sep 15 1983 Standard Telephones and Cables Public Limited Company Controlled release system
4741872, May 16 1986 UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE Preparation of biodegradable microspheres useful as carriers for macromolecules
4749575, Oct 03 1983 Bio-Dar Ltd. Microencapsulated medicament in sweet matrix
4753790, Dec 16 1986 Cadbury Adams USA LLC Sorbitol coated comestible and method of preparation
4762719, Aug 07 1986 Powder filled cough product
4824938, Jun 06 1984 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Water-soluble dry solid containing proteinaceous bioactive substance
4847090, Nov 07 1986 Warner-Lambert Company Confection product and method for making same
4849225, Jul 10 1986 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Process to prepare solid products containing oil-soluble substance
4863865, Aug 26 1983 PAFRA LIMITED, Preservation by cold storage
4873085, Apr 20 1987 Fuisz Technologies Ltd Spun fibrous cosmetic and method of use
4891319, Jul 09 1985 Quadrant Drug Delivery Limited Protection of proteins and the like
4898781, Nov 07 1986 NOVOZYMES A S Water-soluble microcapsules
4910135, Nov 21 1985 Boehringer Mannheim GmbH Water-soluble peroxidase derivatives
4963359, Jan 30 1989 SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC Non-cariogenic confections
4985252, Apr 07 1987 R I PH RECHERCHE INFORMATIQUE ET PHARMACIE S A R L Medication, dietetic product and hygienic product in the form of a powered composition obtained by adsorption of active ingredients on a rapidly dissolving sugar and process for obtaining said composition
4997654, Aug 14 1989 ADAMS CONFECTIONERY CORP ; ADAMS USA INC Method for increasing salivation for xerostomia patients
586504,
DE159826,
EP111216,
EP140489,
EP229810,
EP297887,
EP520748,
EP223221,
EP244771,
EP252750,
GB2126588,
JP7012153,
JPHO5597096,
RE37872, Feb 16 1989 Novartis Pharma AG Storage of materials
WO8600336,
WO8604095,
WO8700196,
WO8705300,
WO8906542,
WO9005182,
///
Executed onAssignorAssigneeConveyanceFrameReelDoc
Aug 28 2001Nektar Therapeutics(assignment on the face of the patent)
Jan 13 2003INHALE THERAPEUTIC SYSTEMS, INC Nektar TherapeuticsCHANGE OF NAME SEE DOCUMENT FOR DETAILS 0135250753 pdf
Dec 31 2008Nektar TherapeuticsNovartis Pharma AGASSIGNMENT OF PATENT RIGHTS0220710001 pdf
Date Maintenance Fee Events


Date Maintenance Schedule
Feb 27 20104 years fee payment window open
Aug 27 20106 months grace period start (w surcharge)
Feb 27 2011patent expiry (for year 4)
Feb 27 20132 years to revive unintentionally abandoned end. (for year 4)
Feb 27 20148 years fee payment window open
Aug 27 20146 months grace period start (w surcharge)
Feb 27 2015patent expiry (for year 8)
Feb 27 20172 years to revive unintentionally abandoned end. (for year 8)
Feb 27 201812 years fee payment window open
Aug 27 20186 months grace period start (w surcharge)
Feb 27 2019patent expiry (for year 12)
Feb 27 20212 years to revive unintentionally abandoned end. (for year 12)